Real world experience with an indigenously manufactured stent Cobal C--a retrospective study
- PMID: 25443606
- PMCID: PMC4223194
- DOI: 10.1016/j.ihj.2014.08.015
Real world experience with an indigenously manufactured stent Cobal C--a retrospective study
Abstract
Background: Second generation bare metal stents made of cobalt chromium alloy are superior to first generation stain less steel stents. The thin struts are shown to reduce clinical and angiographic adverse outcomes.
Objective: To study the long term clinical and angiographic outcomes in patients who underwent coronary angioplasty with an indigenously made cobalt chromium bare metal stents with thin strut Cobal+C™ (Relisys).
Methods: A total of 268 consecutive patients who underwent coronary angioplasty with Cobal+C stents were studied retrospectively. Clinical follow up was done after a minimum period of nine months through telephonic interview and angiographic follow up was done in 80 patients chosen randomly. The end points analyzed included major adverse cardiac events (MACE) at nine months and the rate of binary restenosis at follow up angiogram done between 9 and 15 months post angioplasty.
Results: Thirty four percent were diabetic and 33% had acute myocardial infarction. Females constituted 17%. Mean stent diameter was 2.88 ± 0.28 and mean stent length 18.8 ± 4.2. MACE at nine months was 4.5% with TLR 0.3%. The rate of binary restenosis was 21%. Patients with longer stent lengths and non-compliance with medications had significantly higher rates of binary restenosis.
Conclusions: The use of Relisys Cobal+C stents was associated with good long term clinical and angiographic outcomes as evidenced by low incidence of MACE and binary restenosis rates for a bare metal stent.
Keywords: Bare metal stent; Cobalt chromium stent; Cobalt+C stent; Restenosis.
Copyright © 2014 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
References
-
- Silber S., Albertsson P., Avile's F.F. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology. Eur Heart J. 2005;26:804–847. - PubMed
-
- Hirshfeld J.W., Jr., Schwartz J.S., Jugo R. The M Heart Investigators. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol. 1991;18:647–656. - PubMed
-
- Arjomand H., Turi Zoltan G., McCormick Daniel, Goldberg Sheldon. Percutaneous coronary intervention: historical perspectives, current status, and future directions. Am Heart J. 2003;146:787–796. - PubMed
-
- Elezi S., Kastrati A., Pache J. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol. 1998;32:1866–1873. - PubMed
-
- Hoffmann R., Mintz G.S. Coronary in-stent restenosis — predictors, treatment and prevention. Eur Heart J. 2000;21:1739–1749. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
